Non-Alcoholic Fatty Liver Disease: The Effect of Bile Acids and Farnesoid X Receptor Agonists on Pathophysiology and Treatment

Journal Title: Liver Research – Open Journal - Year 2015, Vol 1, Issue 2

Abstract

Non-alcoholic fatty liver disease (NAFLD) is an emerging epidemic in light of its two predisposing factors, a surge in both obesity and diabetes rates with reports of between 70-80% of obese individuals in Western countries. The disease progression of NAFLD remains elusive but is generally attributed to insulin resistance, lipid metabolism dysfunction, altered immune response to name a few. Potential therapeutic strategies should target one or some of these pathological events in the liver, however currently no specific therapies for NAFLD exist. Thus novel therapeutic approaches to manage the chronic liver disease epidemic are becoming essential. In this review we discuss the evidence supporting the role of bile acid activated Farnesoid X Receptor (FXR) in promoting lipid oxidation, reducing inflammation and fibrosis in the liver. We also examine the potential of FXR agonists, as an attractive class of drugs for the safe and effective treatment of NAFLD.

Authors and Affiliations

Vinood B. Patel

Keywords

Related Articles

Targeted Therapy for Hepatocellular Carcinoma: What`s New?

Hepatocellular carcinoma (HCC), one of the most frequent neoplasms worldwide, causes more than 700,000 deaths per year, and is the third cause of cancer-related mortality.1-3 HCC occurs after years of damage to hepatocyt...

“Cardiac Hepatopathy”: A Review of Liver Dysfunction in Heart Failure

The unique dual circulation of the liver confers relative protection against ischemic injury; however, low oxygen tension in the microcirculation (sinusoidal blood of the hepatic acinus) may render hepatocytes in zone 3...

Comparisons between Portosystemic Shunting Modalities in Patients with Liver Cirrhosis and Portal Hypertension

During almost half of century period, in the Department of Surgery of Portal Hypertension and Pancreatoduodenal Zone of the JSC “Republican Specialized Center of Surgery (named after Academician V. Vakhidov”), portosyste...

Hepatic Myelopathy: Case Report and Review of the Literature

Background: Hepatic Myelopathy (HM) is a rare complication of chronic liver disease usually associated with extensive portosystemic shunt of blood, which has been created surgically or has occurred spontaneously, causing...

Iron and Copper Toxicity in Rat Liver: A Kinetic and Holistic Overview

Iron (Fe) and copper (Cu) overloads in rats showed a dose and time dependent metal accumulation in liver with its associated toxicity. The increased contents of the transition metals markedly enhanced the endogenous free...

Download PDF file
  • EP ID EP556654
  • DOI 10.17140/LROJ-1-106
  • Views 149
  • Downloads 0

How To Cite

Vinood B. Patel (2015). Non-Alcoholic Fatty Liver Disease: The Effect of Bile Acids and Farnesoid X Receptor Agonists on Pathophysiology and Treatment. Liver Research – Open Journal, 1(2), 32-40. https://www.europub.co.uk/articles/-A-556654